Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. It offers cephalosporin antibiotic, antipsychotic, cardiovascular, gastrointestinal, metabolic, neuropsychiatry, respiratory, infectious, anti-inflammatory and analgesics, nutritional supplement, and urology products. The company also provides vitamins, minerals, and other products; and APIs. Yungjin Pharm. Co., Ltd. was founded in 1952 and is headquartered in Seoul, South Korea.
Stock data | 2024 | Change |
---|---|---|
Price | $1.78 | N/A |
Market Cap | $325.38M | N/A |
Shares Outstanding | 182.89M | N/A |
Employees | 574.00 | N/A |